Antineoplastic AgentsCell Line, TumorDrug Screening Assays, AntitumorNeoplasmsAntineoplastic Agents, PhytogenicApoptosisXenograft Model Antitumor AssaysDrug Resistance, NeoplasmInhibitory Concentration 50Cell ProliferationDoxorubicinCell SurvivalMice, NudeAntibiotics, AntineoplasticPlant ExtractsDrug Delivery SystemsTumor Cells, CulturedMolecular StructureDrug SynergismDrug CarriersCisplatinDrug DesignDose-Response Relationship, DrugProdrugsCell CycleCamptothecinEllipticinesAnticarcinogenic AgentsPaclitaxelEtoposideEnzyme InhibitorsPhytotherapyBreast NeoplasmsHT29 CellsGene Expression Regulation, NeoplasticColonic NeoplasmsDrug Resistance, MultipleNanomedicineDrug Evaluation, PreclinicalP-GlycoproteinHCT116 CellsNanoparticlesSignal TransductionStructure-Activity RelationshipTopoisomerase I InhibitorsMolecular Targeted TherapyMCF-7 CellsTopoisomerase InhibitorsCaspasesNeoplasm TransplantationTubulin ModulatorsLung NeoplasmsCaspase 3DNA DamageCell Cycle CheckpointsDNA Topoisomerases, Type IIClinical Trials, Phase I as TopicNeoplasms, ExperimentalAntimetabolites, AntineoplasticTriterpenesCell DivisionCell DeathXanthonesProto-Oncogene Proteins c-bcl-2Tumor Suppressor Protein p53CurcuminBlotting, WesternPlatinumTumor BurdenHistone Deacetylase InhibitorsCoordination ComplexesIntercalating AgentsDrug DiscoveryMice, Inbred BALB CDaunorubicinAngiogenesis InhibitorsNanocapsulesHL-60 CellsAntineoplastic Agents, AlkylatingOplopanaxTransplantation, HeterologousCell Growth ProcessesFlow CytometryDrugs, InvestigationalStilbenesFluorouracilHep G2 CellsBiological ProductsNaphthoquinonesRNA, Small InterferingReactive Oxygen SpeciesNoscapineDown-RegulationLeukemia P388PiperidonesOrganoplatinum CompoundsNeoplasm ProteinsProstatic NeoplasmsIndolesBenzoquinones